A Fresh Approach to Treating Cancer: Targeting Proteins

(DGIwire) – Many headlines from the world of cancer research are focusing on the potential of checkpoint inhibitors—a way of releasing the brakes on immune cells so they can attack cancer cells. But as recently noted on LifeScienceLeader.com, some companies are exploring drugs that could work in combination with checkpoint inhibitors in the hopes of […]

Taking Better Aim at Tumors

(DGIwire) – When it comes to treating cancer, chemotherapy and immunotherapy have proven to be powerful within certain limits. Take immunotherapy: Despite its great promise, it doesn’t help every patient to which it is given—and its track record of success is uneven among different cancers. So notes Douglas J. Swirsky, President and CEO of Rexahn […]

What’s Next in the Fight Against Pancreatic Cancer?

(DGIwire) – Sobering news from the world of medicine: More than 56,000 Americans will be diagnosed with pancreatic cancer in 2019, according to a recent estimate by the American Cancer Society. This represents a two percent increase over the previous year’s diagnoses. While the ACS also states that the disease’s five-year survival rate continues to […]

close